Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A

European Respiratory Journal

Volumn 10, Issue 9, 1997, Pages 1967-1974

  Sun, B ^a   Curstedt, T ^b   Lindgren, G ^c   Franzen B ^a   Alaiya, A A ^a   Calkovska A ^a   Robertson, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c Inovata AB   (Sweden)

Author keywords

Blood proteins; Lung compliance; Meconium; Newborn animals; Pulmonary surfactants; Surfactant protein A

Indexed keywords

LUNG SURFACTANT; PROTEIN A;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FETUS; IMMATURITY; LUNG COMPLIANCE; MECONIUM; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPIRATORY FAILURE;

ALBUMINS; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL PRODUCTS; EDETIC ACID; FIBRINOGEN; HEART RATE; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT, NEWBORN; LUNG COMPLIANCE; MECONIUM; MOLECULAR WEIGHT; PHOSPHOLIPIDS; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RABBITS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURFACE PROPERTIES; SWINE;

EID: 0030963728     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10091967     Document Type: Article

References (29)

1. Walther FJ. Surfactant therapy for neonatal lung disorders other than respiratory distress syndrome. In: Robertson B, Taeusch HW, eds. Surfactant Therapy for Lung Disease. New York, Marcel Dekker, 1996: pp. 461-476.
2. Hawgood S, Clements JA. Pulmonary surfactant and its apoproteins. J Clin Invest 1990; 86: 1-6.
3. r = 26,000-36,000 enhances uptake of liposomes by type II cells. J Biol Chem 1987; 262: 2888-2894.
4. Dobbs LG, Wright JR, Hawgood S, Gonzalez R, Venstrom K, Nellenbogen J. Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc Natl Acad Sci USA 1987; 84: 1010-1014.
5. Suzuki Y, Fujita Y, Kogishi K. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 1989; 140: 75-81.
6. Cockshutt AM, Weitz J, Possmayer F. Pulmonary surfactant-associated protein A enhances the surface properties of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 1990; 29: 8425-8429.
7. Venkitaraman AR, Hall SB, Whitsett JA, Notter RH. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. Chem Phys Lipid 1990; 56: 185-194.
8. Yukitake K, Brown CL, Schlueter MA, Clements JA, Hawgood S. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo. Pediatr Res 1995; 37: 21-25.
9. Yamada T, Ikegami M, Tabor BL, Jobe AH. Effects of surfactant protein-A on surfactant function in preterm ventilated rabbits. Am Rev Respir Dis 1990; 142: 754-757.
10. Wiseman LR, Bryson HM. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf®) in neonatal respiratory distress syndrome. Drugs 1994; 48: 386-403.
11. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959; 234: 466-468.
12. Berggren P, Curstedt T, Grossmann G, Nilsson R, Robertson B. Physiological activity of pulmonary surfactant with low protein content; effect of enrichment with synthetic phospholipids. Exp Lung Res 1985; 8: 29-51.
13. Franzén B, Linder S, Okuzawa K, Kato H, Auer G. Non-enzymatic extraction of cells from clinical tumor material for analysis of gene expression by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1993; 14: 1045-1053.
14. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-4021.
15. Andersson NL. Two-dimensional electrophoresis, operation of the ISO-DALT system. Washington, DC, Large Scale Biology Press, 1992.
16. Rabilloud T, Vuillard L, Gilly C, Lawrence J-J. Silver-staining of proteins in polyacrylamide gels: a general overview. Cell Mol Biol 1994; 40: 57-75.
17. Robertson B, Curstedt T, Johansson J, Jörnvall H, Kobayashi T. Structural and functional characterization of porcine surfactant isolated by liquid-gel chromatography. Prog Respir Res 1990; 25: 237-246.
18. Enhörning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43: 198-203.
19. Sun B, Curstedt T, Robertson B. Surfactant inhibition in experimental meconium aspiration. Acta Paediatr 1993; 82: 182-189.
20. Sun B, Kobayashi T, Curstedt T, Grossmann G, Robertson B. Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. Eur Respir J 1991; 4: 364-370.
21. Weibel ER. Morphometry of the human lung. Academic Press, New York, 1963; pp. 9-39.
22. Whitsett JA, Ohning BL, Ross G, et al. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr Res 1986; 20: 460-467.
23. Notter RH, Penney DP, Finkelstein JN, Shapiro DL. Adsorption of natural lung surfactant and phospholipid extracts related to tubular myelin formation. Pediatr Res 1986; 20: 97-101.
24. Rider ED, Ikegami M, Whitsett JA, Hull W, Absolom D, Jobe AH. Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits. Am Rev Respir Dis 1993; 147: 669-676.
25. Fuchimukai T, Fujiwara T, Takahashi A, Enhörning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987; 62: 429-437.
26. Berggren P, Eklind J, Linderholm B, Robertson B. Bubbles and computer aided image analysis for evaluation of surfactant inhibition. Biol Neonate 1992; 61 (Suppl. 1): 15-20.
27. Seeger W, Stöhr G, Wolf HRD, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 1985; 58: 326-338.
28. Strayer DS, Herting E, Sun B, Robertson B. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Am J Respir Crit Care Med 1996; 153: 1116-1122.
29. Kobayashi T, Nitta K, Takahashi R, Kurashima K, Robertson B, Suzuki Y. Activity of pulmonary surfactant after blocking the associated SP-A and SP-B proteins. J Appl Physiol 1991; 71: 530-536.